5Marc de Gasparo. Angiotensin II and Nitric Oxide Interaction[J] 2002,Heart Failure Reviews(4):347～358
6Bodh I. Jugdutt. Nitric Oxide and Cardioprotection During Ischemia-Reperfusion[J] 2002,Heart Failure Reviews(4):391～405
二级参考文献14
1[1]Arshed A,Quyyumi AA,Dakak N,et al.Nitric oxide activity in the atherosclerotic human coronary circulation.J Am Coll Cardiol,1997,27:30～33
2[2]Engerman R,Kern S,Larson ME.Nerve conduction velocity in dogs is reduced by diabetics and not by galactosemia.Metab Clin Exp.1990,39:638～640
3[3]Mohri M,Takeshita A.Coronary microvascular disease in humans.Jpn Heart J,1999,40(2):97～108
4[4]Keller MW,Segal SS,Kaul S,et al.The behavior of sonicated albumin microbubbles within the microcirculation:A basis for their use during myocardial contrast echocardiograhy.Circ Res,1989,65:458～467
5[5]Flordeliza S,Ron J,william R,et al.Albumin microbubble adherence to human coronary endothelium:Implications for assessment of endothelial function using myocardial contrast echocardiography.J Am Coll Cardiol,1997,30:689～693
6Ferara N,Houck KR,Jakeman LB,et al.Molecular and biological properties of the vascular endothelial growth factor family of proteins[J].Endocrine Rev,1992,13:28-32.
7Ferrara N,Smyth TD.The biology of vascular endothelial growth factor[J].Endocrine Rev,1997,18:4-25.
8Carmeliet P,Collen D.Molecular analysis of blood vessel formation and disease[J].Am J Physiol,1997,237:H2091.
9Senger DR,Ledbetter SR,Claffey KP,et al.Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the αυβ3 integrin osteopontin,and thrombin[J].Am J Pathol,1996,149:293-305.
10Arspe MLL,Dvorak HF.Angiogenesis:a dynamic balance of stimulators and inhibitor[J].Thromb Haemo,1997,78:672.
